Reference number : 236-2018-2019-Q3-00295, amendment number : , agreement type : G, recipient legal name : Mackenzie, Alexander E, recipient country : CA, recipient province : ON, recipient city : Ottawa, recipient postal code : K1H 8L1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 481950.0, agreement start date : 2018-10-01, agreement end date : 2021-09-30, description english : Pharmacologic and RNAi Screens for Myotonic Dystrophy Type 1 foci modulators; towards Novel DM1 therapeutic approaches, description french : Pharmacologic and RNAi Screens for Myotonic Dystrophy Type 1 foci modulators; towards Novel DM1 therapeutic approaches, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada